Temas Resources has secured an estimated C$52,876 Stage 1 contract to test its Regenerative Chloride Leach technology on samples from an unnamed Québec mineral company. The nearby project could offer a regional processing opportunity, while a new governance appointment reshapes the board.
- Estimated C$52,876 Stage 1 RCL validation contract
- Seven-week bench-scale program targeting titanium and iron
- Anonymous Québec VTM/ilmenite project near La Blache and Baie-Comeau
- Anthony Travers appointed director as two directors resign
- Later optimisation, pilot and demonstration stages remain uncommitted
Second Québec customer puts RCL commercialisation to another test
Temas Resources Corp. (ASX:TIO) has added a second independent mineral project to the testing pipeline for its Regenerative Chloride Leach platform, signing an estimated C$52,876 contract with an unnamed Québec company. The work is modest in dollar terms, but strategically more interesting because the customer’s VTM/ilmenite project sits near Temas’ La Blache asset and its proposed RCL demonstration plant at Baie-Comeau.
The Stage 1 program will apply the process to three concentrate samples, with six double-stage leach tests supported by chemical, particle-size and mineralogical analysis. The immediate targets are principally titanium and iron. Temas expects the work to take about seven weeks once samples are received and the program receives its notice to proceed.
The structure follows the stage-gate model used for the company’s SAGA RCL optimisation program, which had moved beyond initial validation into Stage 2 work. For the new customer, Stage 1 is not an optimisation exercise: it is intended to establish whether the process works on the supplied material under Temas’ historical base-case conditions.
Regional proximity creates an option, not a commitment
A successful initial test could lead to a Gate 1 applicability review, followed by possible detailed bench optimisation, minipilot and demonstration-plant stages. Each step requires a separate review, and Temas explicitly cautions that Stage 1 may not meet its objectives or progress further. No licensing agreement, processing contract or infrastructure commitment has been announced.
The commercial logic is nevertheless clear. Temas has been trying to build revenue around RCL technology licensing and services while advancing its own Québec mineral assets, and the new engagement arrives shortly after the company reported its first RCL revenue. If the neighbouring project produces useful results, its location could support discussions around shared infrastructure or regional feed, although those possibilities remain contingent on technical work that has not yet begun.
Audit and governance experience joins a reshaped board
Temas has also appointed Anthony Travers as a non-executive director. Travers is a Chartered Accountant with more than 40 years of professional and corporate experience, including about three decades at KPMG Australia, a partnership at Hall Chadwick and board roles involving ASX-listed companies and mining businesses.
The appointment comes alongside the resignations of Kobi Ben Shabat and Nic Matich, effective 15 November, which the company attributed to personal reasons and reduced time availability. One board seat remains vacant. For a company moving from laboratory validation toward licensing, pilot work and possible demonstration-scale processing, the practical test will be whether the refreshed board can turn a sequence of technical opportunities into funded, repeatable commercial engagements.
Bottom Line?
The next meaningful catalyst is not the contract value but the Stage 1 result, the identity of the customer and whether proximity to Baie-Comeau translates into a funded next-stage program.
Questions in the middle?
- Will the anonymous counterparty’s samples demonstrate that RCL is applicable under base-case conditions?
- Will a positive Gate 1 review lead to funded optimisation or pilot work, rather than stop at validation?
- How will Temas fill the remaining board seat and support the capital needs of its commercialisation strategy?